NAFDAC Arraigns Jos Firm Over Counterfeit Coartem

JOS, NIGERIA — Two men and KRA Nalele Pharmaceutical Limited have been arraigned at the Federal High Court in Jos following a major seizure of fake antimalarials. According to regulatory statements, laboratory analysis of the seized counterfeit coartem malaria tablets revealed that the product contained zero active ingredients of artemether and lumefantrine.
The defendants face three criminal counts under the Counterfeit and Fake Drugs and Unwholesome Processed Foods Act. The enforcement operation took place at a facility on Mango Street in Jos, Plateau State, following a targeted investigation by NAFDAC’s Investigation and Enforcement Directorate into illicit drug distribution networks across northern Nigeria.
Case Summary & NAFDAC Enforcement Operational Timeline
The primary parameters surrounding the arraignment and regulatory response include:
| Parameter | Case Details & Regulatory Action |
| Seized Product | Counterfeit Coartem 20/120mg (Artemether/Lumefantrine) |
| Laboratory Finding | Zero percent active pharmaceutical ingredients (0% API) |
| Defendants | KRA Nalele Pharmaceutical Limited and two unnamed associates |
| Regulatory Warnings | Consumer advisory on open markets, batch checking & MAS verification |
Risks of Distributing Counterfeit Coartem Malaria Tablets
Distributing counterfeit coartem malaria tablets creates severe public health dangers because patients assume genuine antimalarial therapy has begun while their infection progresses unchecked. In vulnerable groups such as young children and pregnant women, untreated uncomplicated malaria can advance rapidly into severe, life-threatening clinical complications within days.
Concurrently, NAFDAC issued broader public warnings against fake pharmaceuticals, bottled water, and cosmetics entering open markets. To help consumers avoid fraudulent drugs, the agency urges patients to purchase prescription medicines solely from licensed pharmacies, inspect packaging for print defects or missing batch numbers, and utilize the Mobile Authentication Service (MAS) code system prior to administration.
Why It Matters: Antimalarials with no active ingredients delay crucial treatment, allowing uncomplicated infections to turn fatal within days.
Source: Peoples Gazette, September 2026



